Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journe...(ommunities touched by cancer. The Dempse...),Health

Date:9/9/2009

ommunities touched by cancer. The Dempsey Center strives to embrace the whole person including body, mind and spirit in a respectful, inclusive and healing environment. All of the Dempsey Center's services are provided free of charge and tax-deductible contributions are welcome. For more information, please visit www.dempseycenter.org.

About Breakaway from Cancer

Founded by Amgen in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, Breakaway from Cancer strives to raise awareness of the important resources available to cancer patients from prevention to education, and patient care to advocacy and financial support. The initiative includes charitable partners the National Coalition for Cancer Survivorship, Patient Advocate Foundation, Prevent Cancer Foundation and The Wellness Community, and it also has joined forces with the Lance Armstrong Foundation and The Patrick Dempsey Center for Hope and Healing at Central Maine Medical Center. Learn more at www.breakawayfromcancer.com.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital
'/>"/>

SOURCE Amgen Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. Amgen to Present at the Thomas Weisel Healthcare Conference
2. Amgen to Present at the Baird Healthcare Conference
3. Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs
4. Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
5. Amgens Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
6. Amgen Announces Webcast of 2009 Second Quarter Financial Results
7. Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
8. Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
9. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
10. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
11. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success